| Menomune-A/C |
103925 |
001 |
351(a) |
Meningococcal Polysaccharide Vaccine, Groups A and C Combined |
For Injection |
Subcutaneous |
50UG/.5ML |
Single-Dose Vial |
1999/12/09
|
Sanofi Pasteur Inc. |
Disc |
Voluntarily Revoked |
|
N/A |
| Menomune-A/C |
103925 |
002 |
351(a) |
Meningococcal Polysaccharide Vaccine, Groups A and C Combined |
For Injection |
Subcutaneous |
50UG/.5ML |
Multi-Dose Vial |
1999/12/09
|
Sanofi Pasteur Inc. |
Disc |
Voluntarily Revoked |
|
N/A |
| Menomune |
103926 |
001 |
351(a) |
Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined |
For Injection |
Subcutaneous |
50UG/.5ML |
Vial |
1999/12/09
|
Sanofi Pasteur Inc. |
Disc |
Voluntarily Revoked |
|
N/A |
| Curosurf |
020744 |
001 |
351(a) |
poractant alfa |
Suspension |
Intratracheal |
120MG/1.5ML (80MG/ML) |
Single-Dose Vial |
1999/11/18
|
Chiesi USA, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Curosurf |
020744 |
002 |
351(a) |
poractant alfa |
Suspension |
Intratracheal |
240MG/3ML (80MG/ML) |
Single-Dose Vial |
1999/11/18
|
Chiesi USA, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Cerezyme |
020367 |
002 |
351(a) |
imiglucerase |
For Injection |
Intravenous |
400UNITS/VIAL |
Single-Dose Vial |
1999/09/22
|
Genzyme Corporation |
Rx |
Licensed |
N/A |
N/A |
| Repronex |
021047 |
001 |
351(a) |
menotropins |
For Injection |
Subcutaneous, Intramuscular |
75IU |
Single-Dose Vial |
1999/08/27
|
Ferring Pharmaceuticals Inc. |
Disc |
Licensed |
N/A |
N/A |
| Repronex |
021047 |
002 |
351(a) |
menotropins |
For Injection |
Subcutaneous, Intramuscular |
150IU |
Single-Dose Vial |
1999/08/27
|
Ferring Pharmaceuticals Inc. |
Disc |
Licensed |
N/A |
N/A |
| Enbrel |
103795 |
002 |
351(a) |
etanercept |
For Injection |
Subcutaneous |
25MG |
Multi-Dose Vial |
1999/05/27
|
Immunex Corporation |
Rx |
Licensed |
N/A |
N/A |
| Thymoglobulin |
103869 |
001 |
351(a) |
Anti-thymocyte Globulin (Rabbit) |
For Injection |
Intravenous |
25MG |
Single-Dose Vial |
1999/05/19
|
Genzyme Corporation |
Rx |
Licensed |
|
N/A |
| Novoseven, Novoseven Rt |
103665 |
001 |
351(a) |
Coagulation Factor VIIa (Recombinant) |
For Injection |
Intravenous |
2.4MG |
Single-Dose Vial |
1999/03/25
|
Novo Nordisk Inc. |
Disc |
Licensed |
|
N/A |
| Actimmune |
103836 |
001 |
351(a) |
interferon gamma-1b |
Injection |
Subcutaneous |
100MCG(2MILLION INTERNATIONAL UNITS)/0.5ML |
Single-Dose Vial |
1999/02/25
|
Horizon Therapeutics Ireland DAC |
Rx |
Licensed |
N/A |
N/A |
| Ontak |
103767 |
001 |
351(a) |
denileukin diftitox |
Injection |
Intravenous |
150MCG/ML (300MCG/2ML) |
Single-Dose Vial |
1999/02/05
|
Eisai, Incorporated |
Disc |
Licensed |
N/A |
N/A |
| Humatrope |
019640 |
005 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
6MG |
Multi-Dose Cartridge |
1999/02/04
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Humatrope |
019640 |
006 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
12MG |
Multi-Dose Cartridge |
1999/02/04
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Humatrope |
019640 |
007 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
24MG |
Multi-Dose Cartridge |
1999/02/04
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Thyrogen |
020898 |
001 |
351(a) |
thyrotropin alfa |
For Injection |
Intramuscular |
0.9MG |
Single-Dose Vial |
1998/11/30
|
Genzyme Corporation |
Rx |
Licensed |
N/A |
N/A |
| Biorab |
103820 |
001 |
351(a) |
Rabies Vaccine Adsorbed |
Injection |
Intramuscular |
1.0ML |
Vial |
1998/11/12
|
Emergent BioDefense Operations Lansing LLC |
Disc |
Licensed |
|
N/A |
| Biothrax |
103821 |
001 |
351(a) |
Anthrax Vaccine Adsorbed |
Injection |
Intramuscular |
0.5ML |
Multi-Dose Vial |
1998/11/12
|
Emergent BioDefense Operations Lansing LLC |
Rx |
Licensed |
|
N/A |
| Biothrax |
103821 |
002 |
351(a) |
Anthrax Vaccine Adsorbed |
Injection |
Subcutaneous |
0.5ML |
Multi-Dose Vial |
1998/11/12
|
Emergent BioDefense Operations Lansing LLC |
Rx |
Licensed |
|
N/A |